MVPs aren't “MIPS Lite.”
They're the ASM training ground.
The 2027 ASM mandate isn't a new program—it's the MVP framework under a different name. Use the voluntary window to stress-test your practice before mandatory participation hits.
Traditional MIPS is ending. Here's the timeline.
Many practices don't realize the transition has already begun. Multispecialty groups face new requirements as early as 2026.
MVP reporting voluntary but highly recommended for specialty groups
Subgroup reporting mandatory for multispecialty groups reporting MVPs
ASM goes live for Cardiology and Low Back Pain specialties
Traditional MIPS begins final sunset (proposed)
MVPs level the playing field.
In Traditional MIPS, a spine surgeon is benchmarked against psychiatrists, chiropractors, and family medicine physicians on broad measures that don't reflect specialty complexity. A cardiologist performing interventions competes against the national average—including clinicians who never see the same patient populations. MVPs change that fundamentally.
Your Quality and Cost scores are benchmarked against all clinicians nationally, regardless of specialty or patient complexity.
Your scores are benchmarked against specialists treating the exact same conditions—a fair comparison that reflects your actual clinical performance.
We use your current QPP data to “dry run” your MVP performance today—so you know exactly how fairer benchmarking affects your score before you commit.
Simpler reporting. Harder accountability.
MVPs reduce the reporting burden—but they're shifting focus from things you can directly control to population health outcomes. That requires a different kind of visibility.
The catch: Population health measures require cost visibility
MVPs include population health measures that you can't manage through documentation alone. Understanding where your high-cost patients are—and why—is now essential. Our platform provides the cost measure insights you need to manage these outcomes, not just report them.
Traditional MIPS vs. MVP strategy
| Dimension | Traditional MIPS | MIPS Value Pathways |
|---|---|---|
| Measures | “Check the box” on 6 disconnected quality measures | 4 measures curated for your specific patient population |
| Benchmarking | Compared to all clinicians regardless of specialty | Compared to peers managing the same chronic conditions |
| Complexity | Manually selecting from 200+ quality options | 21 pre-selected “prix-fixe” menus for clinical excellence |
| Future | Being phased out—sunset proposed for 2029 | The foundation for mandatory ASM participation in 2027 |
The Subgroup Advantage
Don't let one specialty drag down the whole TIN.
In Traditional MIPS, one department's poor performance can affect the entire group's reimbursement. Your high-performing cardiology team subsidizes struggling departments.
We utilize the MVP Subgroup option to silo your specialties. Your high-performing teams secure their own bonuses while we help underperformers identify and fix their specific clinical gaps.
Using MVPs as preparation—not just compliance.
Reporting an MVP is more than a compliance choice—it's a strategic exercise in data visibility. We help you build the internal muscle to understand performance relative to true peers before the results impact reimbursement.
Financial Impact Modeling
We process your data through the lens of both Traditional MIPS and the MVP framework simultaneously. This identifies exactly how your revenue would be affected if the specialty-specific methodology were applied today—before you commit to a reporting path.
Episode-Level Visibility
By utilizing episode-level cost data alongside quality reporting, you gain a clear view of where your practice is most productive—and where the highest risks lie—relative to your highest-performing peers treating the same conditions.
CMS is moving toward a mandatory future through the Ambulatory Specialty Model (ASM). Beginning January 2027, the ASM will put up to 12% of Part B revenue at risk.
If you are in Cardiology, Orthopedics, Pain Management, Anesthesiology, Neurosurgery, or PM&R, you are already operating under the logic of the ASM—the only thing missing today is the mandatory payment adjustment.
The preparation window is now. Use the voluntary MVP period to build the infrastructure for episode visibility and cost benchmarking before the mandate takes effect.
Learn about ASM preparation →See how your practice performs under the MVP framework.
We dry-run your current data through both Traditional MIPS and MVP methodology—so you know exactly what changes before you commit.
Go deeper
MIPS Cost Category
At 30% weight and rising, Cost is no longer ignorable. MVPs score Cost only on pathway-relevant measures.
Learn about Cost →MIPS Reporting & Strategy
Understand how MVPs fit into the broader MIPS framework and the transition timeline.
Learn about MIPS →Ambulatory Specialty Model
Mandatory in 2027 for six specialties. The MVP framework is your training ground.
Learn about ASM →